Showing results (1011-1020 of 9,923) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|July 1, 1991
Strategies to prevent or control infections after bone marrow transplantsJ E Karp, W G Merz, J D Dick, et al.
Bone Marrow Transplantation|July 1, 1991
Disappearance of minimal residual lymphoblastic leukemia cells 6 months after allogeneic bone marrow transplantation without GVHDH Kiyoi, T Naoe, K Kitamura, et al.
Bone Marrow Transplantation|May 19, 2009
Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemiaR K Burt, A Testori, Y Oyama, et al.
Bone Marrow Transplantation|May 19, 2009
Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancerJ A de Souza, M L Davis, G Rondon, et al.
Bone Marrow Transplantation|May 19, 2009
1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myelomaH Chang, X Qi, A Jiang, et al.
Bone Marrow Transplantation|June 30, 2009
Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection preventionA Safdar, G H Rodriguez, C N Mihu, et al.
Bone Marrow Transplantation|June 30, 2009
Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trialsJ W Chien, M Sakai, T A Gooley, et al.
Bone Marrow Transplantation|July 9, 2009
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantationP Chevallier, T Prebet, P Turlure, et al.
Bone Marrow Transplantation|July 9, 2009
Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATGN Hamerschlak, M Rodrigues, D A Moraes, et al.
Bone Marrow Transplantation|September 1, 1991
Oral protein intake and the risk of acute graft-versus-host disease after allogeneic marrow transplantationC L Cheney, N S Weiss, L D Fisher, et al.
Pageof 993